• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form S-8 filed by Quaker Houghton

    5/14/24 4:40:33 PM ET
    $KWR
    Major Chemicals
    Industrials
    Get the next $KWR alert in real time by email
    S-8 1 quakers-82024.htm S-8 Document

    As filed with the Securities and Exchange Commission on May 14, 2024
    Registration No. 333-
     
     
     
    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
     
    FORM S-8
    REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933
     
    QUAKER CHEMICAL CORPORATION
    (Exact Name of Registrant as Specified in Its Charter)
     
    Pennsylvania 23-0993790
    (State or Other Jurisdiction of Incorporation or Organization)
     
    (I.R.S. Employer Identification No.)
    One Quaker Park, 901 E. Hector Street
    Conshohocken, Pennsylvania
     19428-2380
    (Address of Principal Executive Offices) (Zip Code)
     
    Quaker Houghton
    2024 Long-Term Performance Incentive Plan
    (Full Title of the Plan)
     
    Robert T. Traub
    Senior Vice President, General Counsel and Corporate Secretary
    Quaker Chemical Corporation
    901 E. Hector Street
    Conshohocken, Pennsylvania 19428-2380
    Phone Number: (610) 832-4000
    (Name, address, including zip code, and telephone number, including area code, of agent for service)
     
    Copy of all communications to:
    F. Douglas Raymond
    Elizabeth A. Diffley
    Faegre Drinker Biddle & Reath LLP
    One Logan Square, Suite 2000
    Philadelphia, PA 19103-6996
    (215) 988-2700
     
    Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
    Large accelerated filer☒Accelerated filer☐
    Non-accelerated filer☐Smaller reporting company☐
    Emerging growth company☐
    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of Securities Act. ☐



    EXPLANATORY NOTE
    This Registration Statement on Form S-8 (this “Registration Statement”), under the Securities Act of 1933, as amended (the “Securities Act”), registers 900,000 shares of Common Stock, par value $1.00 per share (the “Shares”), of Quaker Chemical Corporation (the “Registrant”) with the U.S. Securities and Exchange Commission (the “Commission”) to be issued pursuant to the Quaker Houghton 2024 Long-Term Performance Incentive Plan, which amends and restates the Registrant’s 2016 Long-Term Performance Incentive Plan (the “Restated Plan”).
    The Restated Plan was approved by the shareholders of the Registrant on May 8, 2024. Pursuant to General Instruction E of Form S-8, this Registration Statement hereby incorporates by reference the contents of the Registrant’s registration statement on Form S-8 filed with the Commission on May 9, 2016 (File No. 333-211238) to the extent not modified or superseded hereby or by any subsequently filed document, which is incorporated by reference herein or therein.
    PART I
    INFORMATION REQUIRED IN THE SECTION 10(a) PROSPECTUS
    The documents containing the information specified in Part I of this Registration Statement will be sent or given to all persons who participate in the Restated Plan, as specified by Rule 428(b)(1) under the Securities Act. These documents are not required to be filed with the Commission as part of this Registration Statement or as prospectuses or prospectus supplements pursuant to Rule 424 of the Securities Act.
    PART II
    INFORMATION REQUIRED IN THE REGISTRATION STATEMENT
    Item 3.    Incorporation of Documents by Reference.
    The following documents filed with the Commission by the Registrant are incorporated by reference in this Registration Statement and made a part hereof:
    1.The Registrant’s Annual Report on Form 10-K for the year ended December 31, 2023, as amended by that Amendment No.1 to the Registrant’s Annual Report on Form 10-K/A, filed on March 14, 2024;
    2.The Registrant’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2024;
    3.The Registrant’s Current Reports on Form 8-K, filed on May 9, 2024; and
    4.The description of the Registrant’s Common Stock, par value $1.00 per share, contained in the Registrant’s Registration Statement on Form 8-A filed with the Commission on August 2, 1996, updated by Exhibit 4.2 to the Registrant’s Annual Report on Form 10-K for the year ended December 31, 2019, including all amendments and reports filed for the purpose of updating that description.
    All documents and reports filed by the Registrant pursuant to Section 13(a), 13(c), 14 and 15(d) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), after the date of this Registration Statement and prior to the filing of a post-effective amendment hereto which indicates that all securities offered hereby have been sold or which deregisters all securities then remaining unsold shall be deemed to be incorporated by reference herein and to be a part hereof from the date of filing of such documents or reports. Any statement contained in a document or report incorporated or deemed to be incorporated by reference herein shall be deemed to be modified or superseded for purposes of this Registration Statement to the extent that a statement contained herein or in any other subsequently filed document or report which also is or is deemed to be incorporated by reference herein modifies or supersedes such statement. Any such statement so modified shall not be deemed to constitute a part of the Registration Statement except as so modified and any statement so superseded shall not be deemed to constitute a part of this Registration Statement.
    Item 4.    Description of Securities.
    Not Applicable.
    Item 5.    Interest of Named Experts and Counsel.
    Not Applicable.



    Item 6.    Indemnification of Directors and Officers.
    Subchapter D of Chapter 17 of the Pennsylvania Business Corporation Law of 1988, as amended (the “PBCL”), contains provisions relating to the indemnification of persons by a Pennsylvania business corporation, including directors and officers of the corporation.
    Sections 1741 and 1742 of the PBCL provide that a business corporation may indemnify directors and officers against liabilities and expenses they may incur as such provided that the particular person acted in good faith and in a manner that person reasonably believed to be in, or not opposed to, the best interests of the corporation, and, with respect to any criminal proceeding, had no reasonable cause to believe such person’s conduct was unlawful. In general, a business corporation’s power to indemnify under these sections does not exist in the case of actions against a director or officer by or in the right of the corporation if the person otherwise entitled to indemnification must have been adjudged to be liable to the corporation unless and only to the extent it is judicially determined that, despite the adjudication of liability but in view of all the circumstances of the case, the person is fairly and reasonably entitled to indemnification for specified expenses. Section 1743 of the PBCL provides that a business corporation shall indemnify directors and officers against expenses they actually and reasonably incur in defending actions against them in such capacities to the extent they are successful on the merits or otherwise in the defense of such actions.
    Section 1744 provides that, unless ordered by a court, any indemnification under Section 1741 or 1742 shall be made by a business corporation only as authorized in the specific case upon a determination that indemnification of a director or officer is proper because the director or officer met the applicable standard of conduct, and such determination must be made: (i) by the board of directors by a majority vote of a quorum of directors not parties to the action or proceeding; (ii) if a quorum is not obtainable or if obtainable and a majority of disinterested directors so directs, by independent legal counsel; or (iii) by the shareholders.
    Section 1745 provides that expenses incurred by a director or officer in defending any action or proceeding referred to in Subchapter D of Chapter 17 of the PBCL may be paid by a business corporation in advance of the final disposition of such action or proceeding upon receipt of an undertaking by or on behalf of the director or officer to repay such amount if it shall ultimately be determined that such director or officer is not entitled to be indemnified by the corporation.
    Section 1746 of the PBCL grants a business corporation broad authority to indemnify its directors and officers for liabilities and expenses incurred in such capacity, except in circumstances where the act or failure to act giving rise to the claim for indemnification is determined by a court to have constituted willful misconduct or recklessness.
    Section 1747 of the PBCL permits a business corporation to purchase and maintain insurance on behalf of any person who is or was a director or officer of the corporation, or is or was serving at the request of the corporation as a representative of another corporation or other enterprise, against any liability asserted against such person and incurred by him or her in any such capacity, or arising out of such person’s status as such, whether or not the corporation would have the power to indemnify the person against such liability under Subchapter D of Chapter 17 of the PBCL. The Registrant currently maintains directors and officers liability insurance on behalf of its directors and officers.
    Section 1748 applies the indemnification and advancement of expenses provisions contained in Subchapter D of Chapter 17 of the PBCL to successor corporations resulting from consolidation, merger or division.
    Section 1750 provides that the indemnification and advancement of expenses pursuant to Subchapter D of Chapter 17 of the PBCL will, unless otherwise provided when authorized or ratified, continue as to a person who has ceased to be a representative of the corporation and shall inure to the benefit of the heirs and personal representative of that person. Any elimination or impairment of the right to indemnification will apply only prospectively unless the Registrant’s Amended and Restated Articles of Incorporation or Amended and Restated by-laws (“By-laws”) expressly authorize a retroactive amendment.
    Section 7.1 of the Registrant’s By-laws provide that the Registrant will indemnify and held harmless its directors and officers to the fullest extent and manner authorized or permitted by the laws of the Commonwealth of Pennsylvania against all expense, liability and loss reasonably incurred or suffered by such persons in connection therewith and such indemnification shall continue as to a person who has ceased to be a director or officer; provided, however, the Registrant will indemnify any such person seeking indemnification in connection with a proceeding initiated by such person only if such proceeding was authorized by the Board of Directors of the Registrant. Where the laws have been amended, such amendment will be applicable only to the extent it allows the Registrant to provide broader indemnification rights than the law allowed the Registrant to provide prior to the amendment. The Registrant will not indemnify a director or officer if a determination is reasonably and promptly made that grounds exist for denying indemnification under the By-laws or under applicable law.
    Item 7.    Exemption from Registration Claimed.
    Not Applicable.



    Item 8.    Exhibits.
    Exhibit
    Number
    Description of Exhibit
    4.1 
    The Quaker Houghton 2024 Long-Term Performance Incentive Plan. Incorporated herein by reference to Exhibit 10.1 as filed by the Registrant within its Current Report on Form 8-K on May 9, 2024.
    4.2
    Registration Rights, dated August 1, 2019, issued to certain members of the management of Global Houghton Ltd. and Gulf Houghton Lubricants, Ltd. by Quaker Chemical Corporation. Incorporated by reference to Exhibit 4.5 as filed by Registrant on Form S-3 on August 29, 2019.
    5.1* 
    Legal Opinion of Faegre Drinker Biddle & Reath LLP.
    23.1* 
    Consent of Faegre Drinker Biddle & Reath LLP (included as part of Exhibit 5.1 hereto).
    23.2* 
    Consent of PricewaterhouseCoopers LLP.
    24.1* 
    Power of Attorney (included as part of the signature page hereto).
    107.1*
    Filing Fee Table.
    *
    Filed herewith.
    Item 9.    Undertakings.
    (a) The undersigned Registrant hereby undertakes:
    1.To file, during any period in which offers or sales are being made, a post-effective amendment to this Registration Statement:
    (i) To include any prospectus required by Section 10(a)(3) of the Securities Act;
    (ii) To reflect in the prospectus any facts or events arising after the effective date of this Registration Statement (or the most
    recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the Registration Statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the Commission pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than 20% change in the maximum aggregate offering price set forth in the “Calculation of Filing Fee Tables” or “Calculation of Registration Fee” table, as applicable, in the effective Registration Statement;
    (iii) To include any material information with respect to the plan of distribution not previously disclosed in the Registration
    Statement or any material change to such information in the Registration Statement;
    provided, however, that paragraphs (a)(1)(i) and (a)(1)(ii) of this section do not apply if the registration statement is on Form S-8 and the information required to be included in a post-effective amendment by those paragraphs is contained in reports filed with or furnished to the Commission by the registrant pursuant to Section 13 or 15(d) of the Exchange Act that are incorporated by reference in this Registration Statement.
    2.That, for the purpose of determining any liability under the Securities Act, each such post-effective amendment shall be deemed to be a new Registration Statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.
    3.To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering.
    (b) The undersigned Registrant hereby undertakes that, for purposes of determining any liability under the Securities Act, each filing of the Registrant’s annual report pursuant to Section 13(a) or 15(d) of the Securities Exchange Act that is incorporated by reference in the Registration Statement shall be deemed to be a new Registration Statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.



    (c) Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of the Registrant pursuant to the foregoing provisions, or otherwise, the Registrant has been advised that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the Registrant of expenses incurred or paid by a director, officer or controlling person of the Registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the Registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue.




    SIGNATURES AND POWER OF ATTORNEY
    Pursuant to the requirements of the Securities Act , the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the Borough of Conshohocken, Commonwealth of Pennsylvania on May 14, 2024.
    QUAKER CHEMICAL CORPORATION
    Registrant
    By:/s/ Robert T. Traub
    Robert T. Traub
    Vice President, General Counsel and Corporate Secretary
    Each person whose signature appears below constitutes and appoints Robert T. Traub and Andrew E. Tometich, and each of them, as such person’s true and lawful attorneys-in-fact and agent, each with full power of substitution and resubstitution, for such person in such person’s name, place and stead, in any and all capacities, to sign any and all amendments (including post-effective amendments) to this Registration Statement, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith, as fully to all intents and purposes as they might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or any of them, or their substitute or substitutes, may lawfully do or cause to be done by virtue hereof.
     Pursuant to the requirements of the Securities Act, this Registration Statement has been signed below by the following persons in the capacities and on the dates indicated.
    SignaturesCapacityDate
    /s/ ANDREW E. TOMETICHChief Executive Officer and PresidentMay 14, 2024
    Andrew E. TometichPrincipal Executive Officer and Director
    /s/ SHANE W. HOSTETTERExecutive Vice President, Chief Financial OfficerMay 14, 2024
    Shane W. HostetterPrincipal Financial Officer
    /s/ JEFFREY J. KUTZVice President, Chief Accounting OfficerMay 14, 2024
    Jeffrey J. KutzPrincipal Accounting Officer
    /s/ MICHAEL F. BARRYDirector, Non-Executive Chair of the BoardMay 14, 2024
    Michael F. Barry
    /s/ RUSSELL R. SHALLERDirectorMay 14, 2024
    Russell R. Shaller
    /s/ CHARLOTTE C. HENRYDirectorMay 14, 2024
    Charlotte C. Henry
    /s/ MARK A. DOUGLASDirectorMay 14, 2024
    Mark A. Douglas
    /s/ JEFFRY D. FRISBYDirectorMay 14, 2024
    Jeffry D. Frisby
    /s/ WILLIAM H. OSBORNEDirectorMay 14, 2024
    William H. Osborne
    /s/ FAY WESTDirectorMay 14, 2024
    Fay West
    /s/ SANJAY HINDUJADirectorMay 14, 2024
    Sanjay Hinduja
    /s/ RAMASWAMI SESHASAYEEDirectorMay 14, 2024
    Ramaswami Seshasayee

    Get the next $KWR alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $KWR

    DatePrice TargetRatingAnalyst
    6/9/2025$146.00Hold → Buy
    Jefferies
    1/7/2025$200.00 → $170.00Overweight → Neutral
    Piper Sandler
    5/16/2024$220.00Overweight
    Piper Sandler
    6/2/2023$250.00Buy
    Stifel
    10/25/2022$196.00Outperform
    RBC Capital Mkts
    1/18/2022$265.00Neutral → Buy
    Seaport Research Partners
    More analyst ratings

    $KWR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by VP, R&D - Advanced Solutions Meagher Kevin K.

    4 - QUAKER CHEMICAL CORP (0000081362) (Issuer)

    1/20/26 4:28:24 PM ET
    $KWR
    Major Chemicals
    Industrials

    SEC Form 3 filed by new insider Meagher Kevin K.

    3 - QUAKER CHEMICAL CORP (0000081362) (Issuer)

    1/9/26 4:10:52 PM ET
    $KWR
    Major Chemicals
    Industrials

    SVP, CHRO Rokosky Kristin converted options into 332 shares and covered exercise/tax liability with 92 shares, increasing direct ownership by 50% to 719 units (SEC Form 4)

    4 - QUAKER CHEMICAL CORP (0000081362) (Issuer)

    12/17/25 4:20:51 PM ET
    $KWR
    Major Chemicals
    Industrials

    $KWR
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Quaker Chemical upgraded by Jefferies with a new price target

    Jefferies upgraded Quaker Chemical from Hold to Buy and set a new price target of $146.00

    6/9/25 7:44:36 AM ET
    $KWR
    Major Chemicals
    Industrials

    Quaker Chemical downgraded by Piper Sandler with a new price target

    Piper Sandler downgraded Quaker Chemical from Overweight to Neutral and set a new price target of $170.00 from $200.00 previously

    1/7/25 8:12:21 AM ET
    $KWR
    Major Chemicals
    Industrials

    Piper Sandler initiated coverage on Quaker Chemical with a new price target

    Piper Sandler initiated coverage of Quaker Chemical with a rating of Overweight and set a new price target of $220.00

    5/16/24 7:34:46 AM ET
    $KWR
    Major Chemicals
    Industrials

    $KWR
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Quaker Houghton Announces Fourth Quarter and Full Year 2025 Earnings and Investor Call

    CONSHOHOCKEN, Pa., Feb. 9, 2026 /PRNewswire/ -- Quaker Houghton (NYSE:KWR) today announced the following schedule and contact information for its fourth quarter and full year 2025 earnings release and investor call. Earnings Release:          Monday, February 23, 2026 (after market close) Visit the investor relations portion of Quaker Houghton's website at https://investors.quakerhoughton.com/ Teleconference:          Tuesday, February 24, 2026, at 8:00 a.m. (ET) Participate live by phone or listen to live audio webcast through the investor relations portion of Quaker Houghton's website at https://investors.quakerhoughton.com/ Dial-in Number:              +1-877-269-7756 (toll-free) +1-201-6

    2/9/26 4:30:00 PM ET
    $KWR
    Major Chemicals
    Industrials

    Quaker Houghton Recognized on Newsweek's List of America's Most Responsible Companies

    CONSHOHOCKEN, Pa., Dec. 8, 2025 /PRNewswire/ -- Quaker Houghton (NYSE:KWR), the global leader in industrial process fluids, has been named one of America's Most Responsible Companies for a third consecutive year. The list, presented by Newsweek and global research firm Statista, Inc., evaluates the top 2,000 U.S. based public companies and recognizes the top 600 across 14 industry subcategories. America's Most Responsible Companies were selected based on publicly available environmental, social and governance performance indicators derived from sustainability reports and an independent perception survey. Joe Berquist, Chief Executive Officer and President stated, "This recognition by Newswee

    12/8/25 4:30:00 PM ET
    $KWR
    Major Chemicals
    Industrials

    Quaker Houghton Announces Quarterly Dividend

    CONSHOHOCKEN, Pa., Nov. 19, 2025 /PRNewswire/ -- The Board of Directors of Quaker Houghton (NYSE:KWR) today declared a quarterly cash dividend of $0.508 per share, payable on January 30, 2026, to shareholders of record at the close of business on January 16, 2026. About Quaker Houghton Quaker Houghton is the global leader in industrial process fluids. With a presence around the world, including operations in over 25 countries, our customers include thousands of the world's most advanced and specialized steel, aluminum, automotive, aerospace, offshore, container, mining, and metalworking companies. Our high-performing, innovative and sustainable solutions are backed by best-in-class technolog

    11/19/25 4:30:00 PM ET
    $KWR
    Major Chemicals
    Industrials

    $KWR
    SEC Filings

    View All

    SEC Form 10-Q filed by Quaker Houghton

    10-Q - QUAKER CHEMICAL CORP (0000081362) (Filer)

    10/30/25 4:43:10 PM ET
    $KWR
    Major Chemicals
    Industrials

    Quaker Houghton filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - QUAKER CHEMICAL CORP (0000081362) (Filer)

    10/30/25 4:39:05 PM ET
    $KWR
    Major Chemicals
    Industrials

    SEC Form 10-Q filed by Quaker Houghton

    10-Q - QUAKER CHEMICAL CORP (0000081362) (Filer)

    7/31/25 4:42:37 PM ET
    $KWR
    Major Chemicals
    Industrials

    $KWR
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    CEO and President Berquist Joseph A bought $49,944 worth of shares (482 units at $103.62), increasing direct ownership by 4% to 12,243 units (SEC Form 4)

    4 - QUAKER CHEMICAL CORP (0000081362) (Issuer)

    5/13/25 4:17:17 PM ET
    $KWR
    Major Chemicals
    Industrials

    Gulf Hungary Holding Korlatolt Felelossegu Tarsasag sold 17,737 shares and bought 17,737 shares, decreasing direct ownership by 78% to 5,017 units (SEC Form 4)

    4 - QUAKER CHEMICAL CORP (0000081362) (Issuer)

    12/5/23 2:11:28 PM ET
    $KWR
    Major Chemicals
    Industrials

    Qh Hungary Holdings Ltd bought 17,737 shares, increasing direct ownership by 0.44% to 4,010,114 units (SEC Form 4)

    4 - QUAKER CHEMICAL CORP (0000081362) (Issuer)

    12/5/23 2:08:14 PM ET
    $KWR
    Major Chemicals
    Industrials

    $KWR
    Leadership Updates

    Live Leadership Updates

    View All

    Astronics Corporation Appoints Fay West to its Board of Directors

    Astronics Corporation (NASDAQ:ATRO), a leading provider of advanced technologies for global aerospace, defense and other mission critical industries, announced the appointment of Fay West to its Board of Directors, effective February 6, 2025. Ms. West brings over two decades of financial leadership experience across various industries. Since April 2021, she has served as Senior Vice President and Chief Financial Officer at Tennant Company (NYSE:TNC), a global leader in designing, manufacturing, and marketing solutions that help create a cleaner, safer, and healthier world. Peter J. Gundermann, Chairman, President and CEO, commented, "We are thrilled to welcome Fay to our Board of Director

    2/7/25 8:00:00 AM ET
    $ATRO
    $KWR
    $TNC
    Military/Government/Technical
    Industrials
    Major Chemicals
    Industrial Machinery/Components

    Quaker Houghton Appoints Joseph Berquist as CEO and President

    CONSHOHOCKEN, Pa., Nov. 18, 2024 /PRNewswire/ -- Quaker Houghton ((", the Company", , NYSE:KWR) announced today that its Board of Directors has appointed Joseph Berquist as Chief Executive Officer and President, and a member of the Board of Directors, effective immediately. Mr. Berquist, who succeeds Andy Tometich as Chief Executive Officer and President, most recently served as Executive Vice President and Chief Commercial Officer for Quaker Houghton. Michael F. Barry, Chairman of the Board of Directors of Quaker Houghton commented, "I want to thank Andy for his three years of leadership at Quaker Houghton. His outside perspective and experiences were valuable to help position the Company f

    11/18/24 4:30:00 PM ET
    $KWR
    Major Chemicals
    Industrials

    Quaker Houghton Appoints Two New Independent Directors to its Board of Directors

    CONSHOHOCKEN, Pa., July 31, 2024 /PRNewswire/ -- Quaker Houghton (NYSE:KWR) today announced the appointment of two new independent directors, Nandita Bakhshi and Lucrèce Foufopoulos-De Ridder, to the company's Board of Directors, effective immediately. Michael F. Barry, Chairman of the Board of Directors of Quaker Houghton, stated: "We are extremely pleased to welcome Nandita and Lucrèce to our Board.  They are both skilled global executives with extensive operational and strategic experience across a diverse set of global businesses and industries.  We are confident these proven leaders will make a meaningful contribution to our Board and the Company." Andy Tometich, Chief Executive Officer

    7/31/24 4:30:00 PM ET
    $KWR
    Major Chemicals
    Industrials

    $KWR
    Financials

    Live finance-specific insights

    View All

    Quaker Houghton Announces Fourth Quarter and Full Year 2025 Earnings and Investor Call

    CONSHOHOCKEN, Pa., Feb. 9, 2026 /PRNewswire/ -- Quaker Houghton (NYSE:KWR) today announced the following schedule and contact information for its fourth quarter and full year 2025 earnings release and investor call. Earnings Release:          Monday, February 23, 2026 (after market close) Visit the investor relations portion of Quaker Houghton's website at https://investors.quakerhoughton.com/ Teleconference:          Tuesday, February 24, 2026, at 8:00 a.m. (ET) Participate live by phone or listen to live audio webcast through the investor relations portion of Quaker Houghton's website at https://investors.quakerhoughton.com/ Dial-in Number:              +1-877-269-7756 (toll-free) +1-201-6

    2/9/26 4:30:00 PM ET
    $KWR
    Major Chemicals
    Industrials

    Quaker Houghton Announces Quarterly Dividend

    CONSHOHOCKEN, Pa., Nov. 19, 2025 /PRNewswire/ -- The Board of Directors of Quaker Houghton (NYSE:KWR) today declared a quarterly cash dividend of $0.508 per share, payable on January 30, 2026, to shareholders of record at the close of business on January 16, 2026. About Quaker Houghton Quaker Houghton is the global leader in industrial process fluids. With a presence around the world, including operations in over 25 countries, our customers include thousands of the world's most advanced and specialized steel, aluminum, automotive, aerospace, offshore, container, mining, and metalworking companies. Our high-performing, innovative and sustainable solutions are backed by best-in-class technolog

    11/19/25 4:30:00 PM ET
    $KWR
    Major Chemicals
    Industrials

    QUAKER HOUGHTON ANNOUNCES THIRD QUARTER 2025 RESULTS

    Q3'25 net sales of $493.8 million, an increase of 7% Y/YOrganic sales volumes increased 3% Y/Y driven by new business wins of approximately 5%Q3'25 net income of $30.5 million and earnings per diluted share of $1.75Non-GAAP net income of $36.3 million and non-GAAP earnings per diluted share of $2.08, an increase of 10% Y/YDelivered adjusted EBITDA of $82.9 million, a 5% increase Y/Y, and adjusted EBITDA margins of 16.8%Generated $51.4 million of operating cash flow in Q3'25; Reduced net leverage ratio to 2.4xCONSHOHOCKEN, Pa., Oct. 30, 2025 /PRNewswire/ -- Quaker Houghton ("the Company") (NYSE:KWR), the global leader in industrial process fluids, announced its third quarter 2025 results toda

    10/30/25 4:30:00 PM ET
    $KWR
    Major Chemicals
    Industrials

    $KWR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Quaker Houghton

    SC 13D/A - QUAKER CHEMICAL CORP (0000081362) (Subject)

    12/17/24 4:18:46 PM ET
    $KWR
    Major Chemicals
    Industrials

    Amendment: SEC Form SC 13D/A filed by Quaker Houghton

    SC 13D/A - QUAKER CHEMICAL CORP (0000081362) (Subject)

    12/12/24 4:59:11 PM ET
    $KWR
    Major Chemicals
    Industrials

    Amendment: SEC Form SC 13D/A filed by Quaker Houghton

    SC 13D/A - QUAKER CHEMICAL CORP (0000081362) (Subject)

    12/9/24 4:07:20 PM ET
    $KWR
    Major Chemicals
    Industrials